Active GLP-1 as prediction Factor of Effect of Sitagliptin on patients with Type 2 diabetes mellitus

Active GLP-1 as prediction Factor of Effect of Sitagliptin on patients with Type 2 diabetes mellitus - A GLP-1 FEST

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010645

Enrollment

100

Registered

2013-05-03

Start date

2011-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Sitagliptin 50mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes Age>=20 years old HbA1c >= 6.9% Agreeing to participate the investigation

Exclusion criteria

Exclusion criteria: Previously taking DPP-IV inhibitor or GLP-1 mimetics

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Secondary

Measure	Time frame
PI/IRI, glucagon, insulin, active GLP-1	—

Countries

Japan

Contacts

Public ContactKushiyama Akifumi

The Institute for Adult Diseases, Asahi Life Foundation Diabetes and Metabolism

kusiyaa-tky@umin.ac.jp03-3639-5501

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026